Mereo Biopharma Group PLC 8-K Filing
Ticker: MREO · Form: 8-K · Filed: Mar 27, 2026 · CIK: 0001719714
| Field | Detail |
|---|---|
| Company | Mereo Biopharma Group PLC (MREO) |
| Form Type | 8-K |
| Filed Date | Mar 27, 2026 |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 8-K filing submitted by Mereo Biopharma Group PLC (ticker: MREO) to the SEC on Mar 27, 2026.
How long is this filing?
Mereo Biopharma Group PLC's 8-K filing is 2 pages with approximately 516 words. Estimated reading time is 2 minutes.
Where can I view the full 8-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 516 words · 2 min read · ~2 pages · Grade level 12.7 · Accepted 2026-03-27 06:10:14
Filing Documents
- mreo-20260326.htm (8-K) — 51KB
- 0001193125-26-127253.txt ( ) — 205KB
- mreo-20260326.xsd (EX-101.SCH) — 57KB
- mreo-20260326_htm.xml (XML) — 6KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized. MEREO BIOPHARMA GROUP PLC Date: March 27, 2026 By: /s/ Charles Sermon Name: Charles Sermon Title: General Counsel